BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Central Standard Time
X-LIC-LOCATION:America/Chicago
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:CST
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:CDT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2026 Annual Meeting by the ºÃÉ«ÏÈÉú\n\nTi
 tle: Industry Therapeutic Update from Novartis Pharmaceuticals: Switch to
  KESIMPTA® (ofatumumab): Bridging clinical data and real-world experience
 s with Gabriel Pardo\, MD\, FAAN and Zenovia\, a real patient\n\nAccess U
 RL: /msa/Public/Events/GetEventURL/23121\n\nLearn More
  About This Event: /msa/Public/Events/Details/23121
DTEND;TZID=Central Standard Time:20260421T124500
DTSTAMP:20260131T122753Z
DTSTART;TZID=Central Standard Time:20260421T114500
LOCATION:/msa/Public/Events/GetEventURL/23121
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from Novartis Pharmaceuticals: Sw
 itch to KESIMPTA® (ofatumumab): Bridging clinical data and real-world exp
 eriences with Gabriel Pardo\, MD\, FAAN and Zenovia\, a real patient
UID:97e55eda-febf-4702-bd2e-3305a64a5ca7
END:VEVENT
END:VCALENDAR